Baxter Healthcare Corporation recalls Norepinephrine Bitartrate in 5% Dextrose Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.
- Products
-
- Norepinephrine Bitartrate in 5% Dextrose Injection
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 13,000 bags
- About this recall
- Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20